Actionable news
0
All posts from Actionable news
Actionable news in HART: Harvard Apparatus Regenerative Technology, Inc.,

Nasdaq Provides HART With 180-Day Period in Which to Regain Compliance With $1.00 Minimum Closing Bid Price Rule

HOLLISTON, MA -- (Marketwired) -- 11/10/15 -- Harvard Apparatus Regenerative Technology, Inc. ("HART") (NASDAQ:HART), a biotechnology company developing bioengineered organs for life-threatening conditions, announced today that it has received a continued listing deficiency notice from The NASDAQ Stock Market LLC because its share price has not met the $1.00 minimum closing bid price requirement for 30 consecutive business days [Nasdaq Listing Rule 5450(a)(1)]. This notice has no immediate effect on the Company's Nasdaq listing or the trading of its common stock.

Nasdaq has provided HART with a 180-day compliance period, until May 2, 2016, in which to regain compliance with the minimum bid price requirement [Nasdaq Listing Rule 5500(a)(2)]. If at any time during the compliance period, the closing bid price of HART's common stock is at least $1.00 per share for at least ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed.

HART's CEO, Jim McGorry, commented, "We are...


More